| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −272.4× | −1.7× | |
| Price / Book | 33.1× | 2.0× | |
| Price / Sales | 24.6× | 3.9× | |
| Price / Free cash flow | 519.8× | −1.6× | |
| EV / EBITDA | −253.2× | −1.1× | |
| Earnings yield | −0.4% | −14.6% | |
| Free cash flow yield | 0.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.18 | −0.70% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $252.05 | −1.37% | $607.41B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.28 | −0.75% | $500.59B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $401.94 | +0.13% | $360.78B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.78 | −0.80% | $357.2B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.20 | −0.28% | $277.86B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.07 | −0.21% | $256.01B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.26 | −1.85% | $250.42B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.13 | −1.24% | $230.92B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.66 | −0.98% | $191.77B | 22.8× | 37.5% | +32.0% |
